Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial

Mengzhao Wang, Yun Fan, Meili Sun, Yongsheng Wang, Yanqiu Zhao, Bo Jin, Ying Hu, Zhigang Han, Xia Song, Anwen Liu, Kejing Tang, Cuimin Ding, Li Liang, Lin Wu, Junzhen Gao, Jianghong Wang, Ying Cheng, Jianying Zhou, Yong He, Xiaorong Dong, Yu Yao, Yan Yu, Huijie Wang, Si Sun, Jian‐An Huang, Jian Fang, Wen Li, Lin Wang, Xiubao Ren, Chengzhi Zhou, Yanping Hu, Dahai Zhao, Runxiang Yang, Fei Xu, Yijiang Huang, Yueyin Pan, Jiuwei Cui, Yan Xu, Zhenfan Yang, Yuankai Shi